ATE445007T1 - Verwendung von pax4 zur proliferation von pankreaszellen - Google Patents

Verwendung von pax4 zur proliferation von pankreaszellen

Info

Publication number
ATE445007T1
ATE445007T1 AT05778088T AT05778088T ATE445007T1 AT E445007 T1 ATE445007 T1 AT E445007T1 AT 05778088 T AT05778088 T AT 05778088T AT 05778088 T AT05778088 T AT 05778088T AT E445007 T1 ATE445007 T1 AT E445007T1
Authority
AT
Austria
Prior art keywords
pax4
cell proliferation
pancreatic cell
wild
cells
Prior art date
Application number
AT05778088T
Other languages
English (en)
Inventor
Benoit Gauthier
Thierry Brun
Claes Wollheim
Roland Wehr
Original Assignee
Univ Geneve
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Geneve filed Critical Univ Geneve
Application granted granted Critical
Publication of ATE445007T1 publication Critical patent/ATE445007T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/34—Sugars
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/16—Activin; Inhibin; Mullerian inhibiting substance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT05778088T 2004-08-11 2005-08-09 Verwendung von pax4 zur proliferation von pankreaszellen ATE445007T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60070404P 2004-08-11 2004-08-11
EP04029743 2004-12-15
PCT/EP2005/008653 WO2006015853A2 (en) 2004-08-11 2005-08-09 Use of pax4 in pancreatic cell proliferation

Publications (1)

Publication Number Publication Date
ATE445007T1 true ATE445007T1 (de) 2009-10-15

Family

ID=56290714

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05778088T ATE445007T1 (de) 2004-08-11 2005-08-09 Verwendung von pax4 zur proliferation von pankreaszellen

Country Status (5)

Country Link
US (1) US20100135963A1 (de)
EP (1) EP1789535B1 (de)
AT (1) ATE445007T1 (de)
CA (1) CA2576573A1 (de)
WO (1) WO2006015853A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2281874A1 (de) 2009-07-31 2011-02-09 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Herstellung von ß-Zellen
US20130210143A1 (en) * 2010-05-20 2013-08-15 Fundacion Publica Andaluza Progreso Y Salud Novel methods for preventing or treating diabetes
FR3087792B1 (fr) * 2018-10-29 2023-09-29 Inovotion Modele animal pour amplifier des cellules tumorales circulantes humaines ou animales
CN118574932A (zh) * 2021-11-30 2024-08-30 加格尔基因治疗有限责任公司 治疗糖尿病的基因治疗方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6099831A (en) * 1992-09-25 2000-08-08 Centre National De La Recherche Scientifique Viral recombinant vectors for expression in muscle cells
US6013638A (en) * 1991-10-02 2000-01-11 The United States Of America As Represented By The Department Of Health And Human Services Adenovirus comprising deletions on the E1A, E1B and E3 regions for transfer of genes to the lung
US5928944A (en) * 1994-02-04 1999-07-27 The United States Of America As Represented By The Department Of Health And Human Services Method of adenoviral-medicated cell transfection
DE69734725T2 (de) * 1996-12-31 2006-08-17 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Neues verfahren zur überprüfung des differenzierungszustands pankreatischer zellen eines säugetiers
US20050054102A1 (en) * 2001-04-19 2005-03-10 Anna Wobus Method for differentiating stem cells into insulin-producing cells
CA2482716A1 (en) * 2002-04-17 2003-10-23 Otsuka Pharmaceutical Co., Ltd. Method of forming pancreatic .beta. cells from mesenchymal cells

Also Published As

Publication number Publication date
EP1789535B1 (de) 2009-10-07
WO2006015853A3 (en) 2006-06-22
US20100135963A1 (en) 2010-06-03
EP1789535A2 (de) 2007-05-30
CA2576573A1 (en) 2006-02-16
WO2006015853A2 (en) 2006-02-16

Similar Documents

Publication Publication Date Title
Rebelo et al. Three‐dimensional co‐culture of human hepatocytes and mesenchymal stem cells: improved functionality in long‐term bioreactor cultures
WO2023030158A1 (en) Alveolar organoids, methods of making and uses thereof
EP3310901B1 (de) In-vitro-herstellung von cholangiozyten
Hilderink et al. Controlled aggregation of primary human pancreatic islet cells leads to glucose‐responsive pseudoislets comparable to native islets
Hegde et al. Dynamic interplay of flow and collagen stabilizes primary hepatocytes culture in a microfluidic platform
He et al. Promotion of hepatic differentiation of bone marrow mesenchymal stem cells on decellularized cell‐deposited extracellular matrix
US20130022986A1 (en) Method for manufacturing pancreatic-hormone-producing cells
EP3401392B1 (de) Verfahren zur herstellung von hepatischen stamm-/vorläuferzellen aus reifen leberzellen mit einer niedermolekularen verbindung
Li et al. Direct differentiation of homogeneous human adipose stem cells into functional hepatocytes by mimicking liver embryogenesis
JPWO2015020113A1 (ja) 膵ホルモン産生細胞の製造法
Gu et al. Heterotypic interactions in the preservation of morphology and functionality of porcine hepatocytes by bone marrow mesenchymal stem cells in vitro
Yang et al. Proliferation and osteogenesis of immortalized bone marrow‐derived mesenchymal stem cells in porous polylactic glycolic acid scaffolds under perfusion culture
Dhanasekaran et al. Human omentum fat‐derived mesenchymal stem cells transdifferentiates into pancreatic islet‐like cluster
US20210403874A1 (en) Method for Producing Stem/Precursor Cells, By Using Low Molecular Weight Compound, From Cells Derived From Endodermal Tissue or Organ
Tharakan et al. Transglutaminases, involucrin, and loricrin as markers of epidermal differentiation in skin substitutes derived from human sweat gland cells
Kawakami et al. Promotion of β-cell differentiation by the alkaloid conophylline in porcine pancreatic endocrine cells
ATE445007T1 (de) Verwendung von pax4 zur proliferation von pankreaszellen
Peng et al. Chemical reprogramming of human blood cells to pluripotent stem cells
Chui et al. Osmolar Modulation Drives Reversible Cell Cycle Exit and Human Pluripotent Cell Differentiation via NF‐κВ and WNT Signaling
US20160168537A1 (en) Differentiated cellular compositions and methods for their preparation and use
Aslanova et al. A chemically defined culture medium containing Rho kinase inhibitor Y-27632 for the fabrication of stratified squamous epithelial cell grafts
Takagi et al. Laminin-511-derived recombinant fragment and Rho kinase inhibitor Y-27632 facilitate serial cultivation of keratinocytes differentiated from human embryonic stem cells
Li et al. Oxygen tension affects terminal differentiation of corneal limbal epithelial cells
Schrader et al. Simulation of an in vitro niche environment that preserves conjunctival progenitor cells
Kim et al. Novel strategy to improve hepatocyte differentiation stability through synchronized behavior‐driven mechanical memory of iPSCs

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties